Literature DB >> 8482924

C-reactive protein increases production of IL-1 alpha, IL-1 beta, and TNF-alpha, and expression of mRNA by human alveolar macrophages.

B Galve-de Rochemonteix1, K Wiktorowicz, I Kushner, J M Dayer.   

Abstract

The concentration of C-reactive protein (CRP) increases in human plasma up to a thousandfold during inflammatory states. Because tissue macrophages have been shown to have receptors for CRP, the question arises of whether these cells may respond to increased local concentrations of CRP by producing cytokines capable of participating in the inflammatory response. Accordingly, we examined the capacity of alveolar macrophages--relatively accessible human macrophages--to produce interleukin-1 (IL-1) and tumor necrosis factor alpha (TNF-alpha) in response to CRP. We found that production of IL-1 alpha, IL-1 beta, and TNF-alpha, as measured by bioassay and immunoassay, increased in a dose-dependent manner after stimulation by CRP and that the levels of the respective mRNAs analyzed by Northern blot increased proportionally. These findings suggest that one of the functions of CRP may be to stimulate the production of IL-1 and TNF by macrophages at inflammatory sites where alterations of capillary permeability combined with an increased serum level lead to enhanced local concentrations of this acute-phase protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8482924     DOI: 10.1002/jlb.53.4.439

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  21 in total

1.  Fcgamma receptor polymorphisms in populations in Ethiopia and Norway.

Authors:  L Van Den Berg; K M Myhr; B Kluge; C A Vedeler
Journal:  Immunology       Date:  2001-09       Impact factor: 7.397

Review 2.  Post-stroke inflammatory response: effects of stroke evolution and outcome.

Authors:  Kiat T Tan; Gregory Y H Lip; Andrew D Blann
Journal:  Curr Atheroscler Rep       Date:  2003-07       Impact factor: 5.113

3.  The combination of CRP isoforms with oxLDL decreases TNF-α and IL-6 release by U937-derived macrophages.

Authors:  Imtissal Krayem; Samer Bazzi; Marc Karam
Journal:  Biomed Rep       Date:  2017-07-21

4.  Systemic inflammation as a predictor of brain aging: Contributions of physical activity, metabolic risk, and genetic risk.

Authors:  Fabian Corlier; George Hafzalla; Joshua Faskowitz; Lewis H Kuller; James T Becker; Oscar L Lopez; Paul M Thompson; Meredith N Braskie
Journal:  Neuroimage       Date:  2018-01-28       Impact factor: 6.556

Review 5.  C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity.

Authors:  Terry W Du Clos; Carolyn Mold
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

6.  Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia.

Authors:  D Xia; D Samols
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

7.  The increased potential for the production of inflammatory cytokines by Kupffer cells and splenic macrophages eight days after thermal injury.

Authors:  J Z Wu; C K Ogle; J X Mao; K Szczur; J E Fischer; J D Ogle
Journal:  Inflammation       Date:  1995-10       Impact factor: 4.092

8.  Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats.

Authors:  U Singh; M R Dasu; P G Yancey; A Afify; S Devaraj; I Jialal
Journal:  J Lipid Res       Date:  2008-02-02       Impact factor: 5.922

9.  Innate immune activation and subversion of Mammalian functions by leishmania lipophosphoglycan.

Authors:  Luis H Franco; Stephen M Beverley; Dario S Zamboni
Journal:  J Parasitol Res       Date:  2012-02-22

10.  Gender differences relating to metabolic syndrome and proinflammation in Finnish subjects with elevated blood pressure.

Authors:  Tiina Ahonen; Juha Saltevo; Markku Laakso; Hannu Kautiainen; Esko Kumpusalo; Mauno Vanhala
Journal:  Mediators Inflamm       Date:  2009-08-20       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.